2026-06-25
GentleGen's G-Lab fully automated platform enables efficient delivery from gene synthesis to antibody expression within 7-10 days
GentleGen leverages its self‑developed GentSynExp 3.0 G‑Lab, a fully automated gene and antibody platform, to build a one‑stop solution covering the entire workflow from gene design, synthesis, and validation to protein expression and antibody development. With its technological advantages in automation, high throughput, and high precision, the company provides the industry with efficient, stable, and cost‑effective R&D support.